
    
      Setting - Cluster randomized trial. Setting - Primary care practices of an integrated
      healthcare system. Participants - 1,493 adults with non-valvular AF seen between April 2014
      and March 2015.

      Intervention - Treatment recommendations were made by an Atrial Fibrillation Decision Support
      Tool (AFDST) based on projections for quality-adjusted life expectancy calculated by a
      decision analytic model that integrates patient-specific risk factors for stroke and
      hemorrhage.
    
  